?:authorAffiliation
|
-
[\'Department of Anesthesiology and Intensive Care, CHU Dijon and University of Burgundy, François Mitterrand University Hospital, LNC UMR1231, 21000, Dijon, France. maxime.nguyensoenen@gmail.com.\', \'Univ. Bourgogne Franche-Comté, LNC UMR1231, 21000, Dijon, France. maxime.nguyensoenen@gmail.com.\', \'INSERM, LNC UMR1231, 21000, Dijon, France. maxime.nguyensoenen@gmail.com.\', \'FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000, Dijon, France. maxime.nguyensoenen@gmail.com.\', \'Inserm, CIC1432, Clinical Epidemiology Unit, Clinical Epidemiology/Clinical Trial Unit, Dijon University Hospital, Dijon, France.\', \'Infectious Diseases Department, François Mitterrand University Hospital, Dijon, France.\', \'Department of Anesthesiology and Intensive Care, CHU Dijon and University of Burgundy, François Mitterrand University Hospital, LNC UMR1231, 21000, Dijon, France.\', \'Univ. Bourgogne Franche-Comté, LNC UMR1231, 21000, Dijon, France.\', \'INSERM, LNC UMR1231, 21000, Dijon, France.\', \'FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000, Dijon, France.\', \'Lipidomic Analytic Platform, University of Burgundy, Dijon, France.\', \'Department of Intensive Care, François Mitterrand University Hospital, Dijon, France.\', \'Laboratory of Clinical Chemistry, François Mitterrand University Hospital, Dijon, France.\']
|